Mailman School of Public Health

Projets

Projets par année 1984 2009 2010 2011 2012 2021 2028

• 13 Non entamé
• 66 Actif
• 970 Terminé

Projets par année

Rechercher les résultats

• Terminé

  Environmental Lead, Thyroid Function &Neurodevelopment

  Factor-Litvak, P. (PI)

  National Institute of Environmental Health Sciences

  8/1/01 → 7/31/04

  Projet

  • Thyroid Function 100%
  • Nerve Cell Differentiation 100%
  • Thyroid Hormone 100%
  • Thyroid 100%
  • Problem Behavior 33%

• Multidisciplinary Training in Population

  Nathanson, C. A. (PI), Astone, N. (PI) & Becker, S. (PI)

  Eunice Kennedy Shriver National Institute of Child Health and Human Development

  5/4/01 → 4/30/13

  Projet

  • Population Research 100%
  • Nutrition Policy 75%
  • Sociology 66%
  • Administrative Structure 50%
  • Health Science 41%

• Is it possible to facilitate self-insight? An empirical examination with the help of an intervention of life reflection

  Staudinger, U. M. (PI)

  Deutsche Forschungsgemeinschaft

  1/1/01 → 12/31/04

  Projet

  • Empirical 100%

• Florida Node Alliance of the Drug Abuse Clinic Trials Network

  Szapocznik, J. (PI) & Metsch, L. (CoPI)

  9/30/00 → 8/31/15

  Projet

  • Drug Abuse 100%
  • Group Therapy 100%
  • Human Immunodeficiency Virus 50%
  • Adolescence 50%
  • Substance Abuse 33%

• MEASURING COGNITIVELY ACTIVE LIFE EXPECTANCY

  Pressley, J. C. (PI)

  National Institute on Aging

  9/30/00 → 8/31/02

  Projet

  • Secondary Data 100%
  • Medicare 100%
  • Life Cycle 100%
  • Cognitive Performance 50%
  • Survey Question 50%

• TUBERCULOSIS ADHERENCE PARTNERSHIP ALLIANCE STUDY

  El-Sadr, W. M. (PI)

  National Heart, Lung, and Blood Institute

  9/30/00 → 1/31/07

  Projet

  • Process Model 100%
  • Tuberculosis 100%
  • Self-Efficacy 66%
  • Health Belief 66%
  • Healthcare 33%

• STARS: STUDENTS TALKING ABOUT REAL SOLUTIONS

  Wingood, G. (PI)

  National Institute of Mental Health

  9/29/00 → 8/31/06

  Projet

  • Relapse Prevention 100%
  • Human Immunodeficiency Virus 100%
  • Risk Reduction 23%
  • Cost Effectiveness Analysis 22%
  • Human Immunodeficiency Virus Risk Behavior 15%

• SELF-CARE IN SYMPTOM MANAGEMENT AT THE END OF LIFE

  Siegel, K. (PI)

  National Institute of Nursing Research

  9/1/00 → 8/31/05

  Projet

  • Self Care 100%
  • Symptom Management 100%
  • Self-Care 100%
  • Clinical Management 60%
  • Diseases 60%

• Supplemental Training in Making Data FAIR and AI/ML Ready

  Factor-Litvak, P. (CoPI), Brandt-Rauf, P. (PI), Whyatt, R. (PI), Guilarte, T. (PI), Graziano, J. (PI) & Navas-Acien, A. (PI)

  National Institute of Environmental Health Sciences

  7/1/00 → 6/30/22

  Projet

  • Public Health 100%
  • Nutrition Policy 100%
  • Environmental Health 93%
  • Respiratory Disease 77%
  • Malignant Neoplasm 77%

• HIV PREVENTION TRIAL UNIT (PRIDE NYC PROGRAM)

  El-Sadr, W. M. (PI)

  National Institute of Allergy and Infectious Diseases

  7/1/00 → 6/30/07

  Projet

  • Human Immunodeficiency Virus 100%
  • HIV 100%
  • Medicine 28%
  • Efficacy Study 14%
  • Clinical Trial 14%

• SOUTHERN AFRICA-NEW YORK HIV VACCINE TRIALS UNIT

  Abdool Karim, S. (PI), Tucker, T. (PI) & Gray, G. (PI)

  National Institute of Allergy and Infectious Diseases

  7/1/00 → 2/28/05

  Projet

  • Human Immunodeficiency Virus Vaccine 100%
  • HIV Vaccine 100%
  • HIV 31%
  • Human Immunodeficiency Virus 25%
  • Clinical Trial 12%

• SOUTH AFRICA MRC HIV PREVENTION TRIALS UNIT

  Abdool Karim, S. (PI) & Ramjee, G. (PI)

  National Institute of Allergy and Infectious Diseases

  7/1/00 → 5/31/08

  Projet

  • Human Immunodeficiency Virus 100%
  • HIV 100%
  • Antimicrobial Agent 50%
  • Africans 27%
  • Phase I Trials 20%

• Power and Pollution: The Social History of Lead, Silica and Plastics in Post War America

  Rosner, D. (PI) & Markowitz, G. (CoPI)

  National Science Foundation

  7/1/00 → 12/31/02

  Projet

  • Social History 100%
  • Diseases 100%
  • Nutrition Policy 100%
  • Americas 100%
  • Post-war America 100%

• Oral Infections and Vascular Disease Epidemiology Study (INVEST)

  Desvarieux, M. (PI)

  National Institute of Dental and Craniofacial Research

  6/15/00 → 2/29/16

  Projet

  • Mouth Infection 100%
  • Atherosclerosis 81%
  • Periodontal Disease 79%
  • Vascular Disease 79%
  • Disease Epidemiology 68%

• SYMPTOMS AND ILLNESS BEHAVIORS OF HIV-INFECTED ADULTS

  Siegel, K. (PI)

  National Institute on Aging

  6/1/00 → 5/31/05

  Projet

  • Healthcare 100%
  • Self-Care 100%
  • Human Immunodeficiency Virus 100%
  • Diseases 100%
  • Adherence to Treatment 50%

• ARTHRITIS AMONG LATINOS: A STUDY BASED ON NATIONAL DATA

  Abraido-Lanza, A. F. (PI)

  National Institute of Arthritis and Musculoskeletal and Skin Diseases

  6/1/00 → 5/31/03

  Projet

  • Arthritis 100%
  • Prevalence 55%
  • Health Service 44%
  • Health Care 44%
  • Healthcare 44%

• Health Effects and Geochemistry of Arsenic

  Navas-Acien, A. (PI) & Graziano, J. (PI)

  National Institute of Environmental Health Sciences

  6/1/00 → 3/31/21

  Projet

  • Geochemistry 100%
  • Bangladesh 84%
  • Superfund Site 63%
  • Maine 48%
  • United States of America 44%

• VULNERABILITY OF THE FETUS/INFANT TO PAH, PM2.5 AND ETS.

  Perera, F. P. (PI)

  National Institute of Environmental Health Sciences

  2/1/00 → 1/31/06

  Projet

  • Polycyclic Aromatic Hydrocarbon 100%
  • Passive Smoking 100%
  • Particular Matter 2.5 100%
  • Fetus Growth 28%
  • Toddlers 28%

• Face Mask Fit Virtual Simulation

  Staudinger, U. M. (CoPI), Perrig-chiello, P. P. (PI), Höpflinger, F. F. (CoPI), Limited, N. S. (CoI) & Mac Donald, J. C. J. C. (PI)

  Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung

  1/1/00 → 11/30/20

  Projet

  • Public Transport 100%
  • Legislation 100%
  • COVID-19 100%
  • Know How 100%
  • Health Professionals 100%

• Environmental As, pregnancy, and children's health

  Graziano, J. (PI)

  National Institute of Environmental Health Sciences

  10/1/99 → 9/30/02

  Projet

  • Cacodylic Acid 100%
  • Methanearsonic Acid 100%
  • Folic Acid 50%
  • Multivitamin 50%
  • Vitamin B12 25%

• TROGLITAZONE IN MODERATE TO SEVERE INSULIN RESISTANCE

  Rowe, J. W. (PI)

  10/1/99 → 9/30/00

  Projet

  • Troglitazone 100%
  • Insulin Resistance 100%

• Trace Metals Core

  Graziano, J. (PI)

  National Institute of Environmental Health Sciences

  10/1/99 → 3/31/11

  Projet

  • Trace Metal 100%
  • Inductively Coupled Plasma 47%
  • Inductively Coupled Plasma Mass Spectrometry 25%
  • Urine Sampling 25%
  • Urinary System 25%

• INSULIN &INSULIN LIKE GROWTH FACTOR 1--INSULIN RESISTAN

  Rowe, J. W. (PI)

  National Center for Research Resources

  10/1/99 → 9/30/00

  Projet

  • Insulin Resistance 100%
  • Somatomedin C 100%
  • Insulin 100%
  • Fibrinogen 100%
  • Somatomedin 100%

• MHCRC IN SCHIZOPHRENIA STUDIES

  Gorman, J. M. (PI), Amador, X. F. (CoPI), Gilliam, T. C. (CoPI), Laruelle, M. A. (CoPI) & Susser, E. S. (CoPI)

  9/30/99 → 12/31/02

  Projet

  • Neuroimmunology 100%
  • Neuroscience 100%
  • Brain Imaging 100%
  • Genetic Epidemiology 100%
  • Clinical Research 100%

• WOMEN LIVING WITH HIV IN TWO TIME PERIODS

  Siegel, K. (PI)

  National Institute of Mental Health

  9/30/99 → 5/31/05

  Projet

• Evaluation of the Foundation's Active Living by Design program

  Brown, L. D. (PI) & Hilber, C. (PI)

  Robert Wood Johnson Foundation

  9/1/99 → 8/31/09

  Projet

  • Physical Activity 100%
  • Program Design 100%
  • Built Environment 100%
  • Social Economics 66%
  • Case Study 50%

• Efficient Condensation of Spatial/Temporal Data

  McKeague, I. W. (PI)

  National Science Foundation

  8/15/99 → 7/31/02

  Projet

  • Nonparametric Curve Estimation 100%
  • Statistical Model 100%
  • Spline 100%
  • Clustering 100%
  • Spatial Point Process 100%

• CYCLIN D1 AS BIOMARKER OF BREAST CANCER RISK

  Tang, D. (PI)

  National Cancer Institute

  7/1/99 → 6/30/02

  Projet

  • Biological Marker 100%
  • Cyclin D1 100%
  • Breast Cancer 100%
  • Neoplasm 33%
  • Western Blot 16%

• CANCER RELATED BEHAVIORS AMONG LATINOS AND NON-LATINO WH

  Abraido-Lanza, A. F. (PI)

  National Cancer Institute

  6/18/99 → 5/31/01

  Projet

  • Acculturation 100%
  • Behavior (Neuroscience) 100%
  • Healthcare 50%
  • Alcohol Abuse 25%
  • Health-Related Behavior 25%

• The Columbia Center for Children's Environmental Health

  Perera, F. P. (PI)

  National Institute of Environmental Health Sciences

  11/1/98 → 9/29/15

  Projet

  • Asthma 100%
  • Allergen 83%
  • Continuing Medical Education 80%
  • Grand Rounds 80%
  • Pediatrics 80%

• CORE--NEURODEVELOPMENTAL AND GENETIC EPIDEMIOLOGY RESEARCH CORE

  Susser, E. S. (PI)

  National Institute of Mental Health

  10/1/98 → 9/30/01

  Projet

  • Genetic Epidemiology 100%
  • Rubella 100%
  • Nerve Cell Differentiation 50%
  • Brain Imaging 50%
  • Cerebrovascular Accident 50%

• DENTAL AMALGAMS &NEUROPSYCHOLOGICAL FUNCTION

  Factor-Litvak, P. (PI)

  National Center for Research Resources

  10/1/98 → 9/30/00

  Projet

  • Dental Amalgam 100%
  • Urinary System 66%
  • Executive Function 55%
  • Tissue (Anatomy) 55%
  • Kidney Function 33%

• RESEARCH PROJECT ON GROWTH AND DEVELOPMENT

  Perera, F. P. (PI)

  National Institute of Environmental Health Sciences

  10/1/98 → 9/30/99

  Projet

  • Essential Fatty Acid 100%
  • Antioxidant 100%
  • Environmental Exposure 100%
  • Polycyclic Aromatic Hydrocarbon 100%
  • Early Childhood Development 100%

• Health, Wealth, and the City: Engineering Social and Urban Change in New York City, 1865 to 1920.

  Rosner, D. (PI) & Fairchild, A. L. (CoPI)

  National Science Foundation

  10/1/98 → 4/30/01

  Projet

  • Social Engineering 100%
  • Wealth 100%
  • Curriculum 50%
  • History of Public Health 50%
  • Annual Report 50%

• CHARACTERIZATION OF INSULIN &INSULIN LIKE GROWTH FACTOR RESPONSES

  Rowe, J. W. (PI)

  10/1/98 → 9/30/00

  Projet

  • Insulin Resistance 100%
  • Somatomedin 100%
  • Insulin 100%
  • Insulin Release 33%
  • Somatomedin C 33%

• MOTHERS &NEWBORNS STUDY

  Perera, F. P. (PI)

  National Center for Research Resources

  10/1/98 → 9/30/00

  Projet

  • Neonatal Infant 100%
  • Polycyclic Aromatic Hydrocarbon 100%
  • Passive Smoking 83%
  • Asthma 66%
  • Tobacco Smoke 66%

• PROSTATE CANCER RISK IN RELATION TO NUTRITION

  Lumey, L. H. (PI)

  National Cancer Institute

  9/30/98 → 9/29/01

  Projet

  • Prostate Cancer 100%
  • Cancer Risk 100%
  • Nutrition 100%
  • Body Size 100%
  • Critical Potential 50%

• MECHANISMS OF NEUROPATHOGENESIS IN BORNA DISEASE

  Hornig, M. (PI)

  National Institute of Mental Health

  7/15/98 → 6/30/03

  Projet

  • Borna Disease Virus 100%
  • Borna Disease 100%
  • Rhesus Monkey 50%
  • Infection 42%
  • Virus Infection 35%

• SEXUAL RISK REDUCTION AMONG MEN WITH MENTAL ILLNESS

  Susser, E. S. (PI)

  National Institute of Mental Health

  7/1/98 → 6/30/04

  Projet

  • Risk Reduction 100%
  • Severe Mental Illness 100%
  • Clinical Trial 100%
  • Human Immunodeficiency Virus 66%
  • Randomized Clinical Trial 50%

• Center for Environmental Health in Northern Manhattan

  Baccarelli, A. (PI), Santella, R. M. (PI), Chillrud, S. (PI), Factor-Litvak, P. (PI), Hernandez, D. (PI), Perzanowski, M. S. (PI) & Graziano, J. (PI)

  National Institute of Environmental Health Sciences

  7/1/98 → 3/31/22

  Projet

  • Diseases 100%
  • Exposure Assessment 80%
  • Public Health 61%
  • Degenerative Disease 60%
  • Trace Metal 60%

• CELL CYCLE CHECKPOINT CONTROL IN BLOOMS SYNDROME

  Freyer, G. A. (PI)

  National Institute of Environmental Health Sciences

  2/5/98 → 1/31/03

  Projet

  • Bloom Syndrome 100%
  • Cell Cycle Checkpoint 100%
  • Genome Instability 33%
  • Gene Product 33%
  • Genetics 33%

• CHEMOPREVENTION IN CIGARETTE SMOKERS

  Perera, F. P. (PI)

  National Center for Research Resources

  10/1/97 → 9/30/00

  Projet

  • Cigarette Smoking 100%
  • Chemoprophylaxis 100%
  • Cigarette Filter 100%
  • DNA Damage 80%
  • Placebo 70%

• HORMONAL REGULATION OF MEMBRANE PHENOTYPE

  Graziano, J. (PI)

  National Center for Research Resources

  10/1/97 → 9/30/00

  Projet

  • Hormonal Regulation 100%
  • Plasminogen Activator Inhibitor 1 100%
  • Tissue Plasminogen Activator 100%
  • Hepatocyte 33%
  • Gene Expression 33%

• Cancer Research Core

  Perera, F. P. (PI) & Hei, T. K. (PI)

  National Institute of Environmental Health Sciences

  10/1/97 → 3/31/08

  Projet

  • Cancer Research 100%
  • Malignant Neoplasm 100%
  • Cohort Effect 40%
  • Carcinogenesis 40%
  • Epidemiology 33%

• Trace Metals Facility Services/Core

  Graziano, J. (PI)

  National Institute of Environmental Health Sciences

  10/1/97 → 3/31/13

  Projet

  • Trace Metal 100%
  • Biochemical Analysis 35%
  • Iron 35%
  • Quality Control 35%
  • Isotopes of Potassium 35%

• TROGLITAZONE WITH/WITHOUT INSULIN FOR INSULIN REQUIRING PATIENTS WITH NIDDM

  Rowe, J. W. (PI)

  National Center for Research Resources

  10/1/97 → 9/30/99

  Projet

  • Troglitazone 100%
  • Non Insulin Dependent Diabetes Mellitus 100%
  • Maturity Onset Diabetes of the Young 100%
  • Clinical Trial 50%
  • Placebo 50%

• Exposure Assessment Facility/Service Cores

  Santella, R. M. (PI) & Kinney, P. L. (PI)

  National Institute of Environmental Health Sciences

  10/1/97 → 3/31/13

  Projet

  • Exposure Assessment 100%
  • Environmental Health 76%
  • Biological Marker 46%
  • Design Method 35%
  • Observatory 35%

• INHALED HUMAN INSULIN VS USUAL SUBCUTANEOUS INSULIN THERAPY IN IDDM

  Rowe, J. W. (PI)

  10/1/97 → 9/30/00

  Projet

  • Recombinant Human Insulin 100%
  • Human Insulin 100%
  • Insulin Treatment 100%
  • Insulin Dependent Diabetes Mellitus 100%

• INHALED HUMAN INSULIN VS USUAL SQ HUMAN INSULIN THERAPY IN NIDDM

  Rowe, J. W. (PI)

  National Center for Research Resources

  10/1/97 → 9/30/99

  Projet

  • Human Insulin 100%
  • Maturity Onset Diabetes of the Young 100%
  • Recombinant Human Insulin 100%
  • Insulin Therapy 100%
  • Non Insulin Dependent Diabetes Mellitus 100%

• Neuroscience Research Core

  Mayeux, R. (PI) & Graziano, J. (PI)

  National Institute of Environmental Health Sciences

  10/1/97 → 3/31/08

  Projet

  • Degenerative Disease 100%
  • Neurotoxicology 100%
  • Neurodegenerative Disorder 100%
  • Diseases 83%
  • Genetic Susceptibility 33%